跳至主要内容
临床试验/NCT06552117
NCT06552117尚未招募不适用

ElastoMRI Evaluation of Hepatic Metastases in Colorectal Cancer

Assistance Publique - Hôpitaux de Paris0 个研究点目标入组 50 人开始时间: 2024年8月10日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
50
主要终点
Evaluate elasticity obtained by elasto MRI according to the systemic treatments selected: conventional purified type Folfox or associated with a targeted therapy

研究概览

简要总结

Currently, the tumor response of operated colorectal liver metastases is assessed by histology of the resection specimen.The histological data make it possible to define categories (responder, partial responder, non-responder).

Overall survival (OS: overall survival) after surgery crucially depends on the response to neoadjuvant chemotherapy. Current criteria for predicting histological response in preoperative imaging are not satisfactory.

The working hypothesis is that it is possible to better differentiate the tissue response to conventional chemotherapies and anti-angiogenics through MRI elastography by quantifying the changes in tissue mechanical properties induced by systemic treatments.

The objectives is to evaluate the mechanical properties obtained by elasto MRI according to the systemic treatments envisaged: conventional chemotherapy such as Folfox or combined with targeted therapy

详细描述

Currently, the tumor response of operated colorectal liver metastases is assessed by histology of the resection specimen.The histological data make it possible to define categories (responder, partial responder, non-responder).

Overall survival (OS: overall survival) after surgery crucially depends on the response to neoadjuvant chemotherapy. Current criteria for predicting histological response in preoperative imaging are not satisfactory.

The working hypothesis is that it is possible to better differentiate the tissue response to conventional chemotherapies and anti-angiogenics through MRI elastography by quantifying the changes in tissue mechanical properties induced by systemic treatments.

The objectives is to evaluate the mechanical properties obtained by elasto MRI according to the systemic treatments envisaged: conventional chemotherapy such as Folfox or combined with targeted therapy

This is an open, non-randomized, non-comparative trial with three parallel groups

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients ≥18 years old, followed for colorectal cancer with hepatic metastases.
  • The diagnosis of metastasis can be made: either by tumor biopsy or by the appearance during follow-up of colorectal cancer of at least one liver lesion with the characteristics of metastasis (fibrous tumor type imaging)
  • Patient with an indication to receive first-line chemotherapy for liver metastases, whether or not associated with targeted therapy
  • Patient with at least one hepatic metastasis greater than 2cm

排除标准

  • Patients not affiliated with social security
  • Pregnant or breastfeeding women
  • Patients under guardianship, curatorship or safeguard of justice
  • Patients with a contraindication to MRI or to the injection of contrast agent in MRI. The classic contraindications for MRI are defined by the French Society of Radiology:http://www.sfrnet.org/sfr/professionnels/1-fiche-information-patients/irm/index.phtml
  • Lack of signed patient consent

结局指标

主要结局

Evaluate elasticity obtained by elasto MRI according to the systemic treatments selected: conventional purified type Folfox or associated with a targeted therapy

时间窗: 6 months

The Primary endpoint is variation in the measurement of the elasticity of the metastases by elastography-MRI between the baseline MRI and the follow-up MRI according to the morphological response criteria RECIST1.1

Evaluate viscosity obtained by elasto MRI according to the systemic treatments selected: conventional purified type Folfox or associated with a targeted therapy

时间窗: 6 months

The Primary endpoint is variation in the measurement of the viscosity of the metastases by elastography-MRI between the baseline MRI and the follow-up MRI according to the morphological response criteria RECIST1.1

次要结局

  • Compare the type of tumor response of liver MRI with liver CT(Preoperative for the group of resectable patients and after 4 cycles for the potentially resectable and unresectable groups)
  • Correlate in operated patients the mechanical properties obtained by elastomeric MRI with the histological response.(by preoperative)
  • Compare the metastases detected of liver MRI with liver CT(Preoperative for the group of resectable patients and after 4 cycles for the potentially resectable and unresectable groups)
  • Compare tumour response of liver MRI with liver CT(Preoperative for the group of resectable patients and after 4 cycles for the potentially resectable and unresectable groups)

研究者

申办方类型
Other
责任方
Sponsor

相似试验